Management of Recurrent UTIs in Elderly Women

Introduction to Management

The European Association of Urology recommends initiating vaginal estrogen therapy as first-line treatment for elderly women with recurrent UTIs and negative diagnostic workup, followed by sequential non-antimicrobial interventions, reserving antibiotic prophylaxis only after all other measures have failed 1, 2.

The American Urological Association suggests documenting recurrent UTI with urine culture during symptomatic episodes, defined as ≥3 UTIs in 12 months or ≥2 UTIs in 6 months, to confirm the diagnosis 1, 5.
The American College of Radiology states that imaging is of low yield in patients without underlying risk factors who respond promptly to therapy, and therefore, cystoscopy and upper tract imaging should not be routinely obtained in patients presenting with recurrent UTIs when initial workup is negative 2, 4, 6.

The European Urology guidelines recommend prescribing vaginal estrogen cream as the preferred formulation, with a 75% reduction in recurrent UTIs vs. 36% with vaginal rings 3.
Vaginal estrogen restores lactobacillus colonization and reduces vaginal pH, and this recommendation applies regardless of whether the patient has a uterus, as vaginal estrogen has minimal systemic absorption and does not require progesterone co-administration 2, 3.

The European Urology guidelines suggest methenamine hippurate 1 gram twice daily, which can be combined with vaginal estrogen for additive effect, as a sequential non-antimicrobial option if vaginal estrogen fails after 6-12 months 1, 3, 7.
Immunoactive prophylaxis (OM-89/Uro-Vaxom) is also recommended, as an oral immunostimulant that decreases recurrent UTI (RR 0.61, 95% CI 0.48-0.78) 1, 7.

The American Urological Association recommends reserving antimicrobial prophylaxis for cases where all non-antimicrobial interventions have failed, and suggests using nitrofurantoin 50 mg nightly for 6-12 months as a preferred agent 1, 3, 7.

The European Urology guidelines recommend treating acute cystitis with fosfomycin trometamol 3 g single dose, nitrofurantoin 100 mg twice daily for 5 days, or trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days, based on local antibiogram 1.

The American College of Radiology advises against prescribing oral/systemic estrogen for UTI prevention, as it is completely ineffective and carries unnecessary risks, and against treating asymptomatic bacteriuria, as it fosters antimicrobial resistance and increases recurrent UTI episodes 1, 2, 7.

The Journal of the American College of Radiology notes that postmenopausal women are at increased risk for recurrent UTI in the presence of urinary incontinence, cystocele, or high post-void residual volumes, and that symptoms of UTI may be less clear in older adults, requiring careful evaluation of chronicity 4, 5, 6.